Home-grown private equity (PE) firm ChrysCapital has decided to offload its remaining stake in Intas Pharmaceuticals Ltd, a privately held drug maker based in Ahmedabad, and is holding discussions to dilute at least half of the stake shortly, two people aware of the development said.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
